• Tidak ada hasil yang ditemukan

links.lww.com/TA/B495

N/A
N/A
Protected

Academic year: 2024

Membagikan "links.lww.com/TA/B495"

Copied!
5
0
0

Teks penuh

(1)

Supplemental Digital Content 5

eTable 5. Quality assessment for weight-based dosing regimens using GRADE methodology

Number of

Studies Study design Limitations Inconsistency Indirectness Imprecision Other considerations

Quality of Evidence VTE Incidence

5 Observational Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW ◯◯

⨁⨁

anti-Xa Concentration

6 Observational,

RCT Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision Not Serious2 LOW ◯◯

⨁⨁

Bleeding Complications

5 Observational Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW ◯◯

⨁⨁

1. Serious limitations include small sample size, single-center studies, loss to follow up. Additionally, Bickford et al.

(2013) was a one-arm prospective cohort which lacked a comparator group.

2. Most studies draw anti-Xa levels after the third dose of VTE chemoprophylaxis has been administered. Ludwig (2011) took measurements after the second and third doses. However, all included studies did use the same target range of 0.2-0.6 IU/mL.

(2)

Supplemental Digital Content 6

eTable 6. Quality assessment for weight-stratified dosing regimens using GRADE methodology

Number of

Studies Study design Limitations Inconsistency Indirectness Imprecision Other

considerations Quality of Evidence VTE Incidence

4 Observational Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW

◯◯

⨁⨁

anti-Xa Concentration

3 Observational Serious1 No serious

inconsistency

No serious indirectness

No serious

imprecision None LOW

◯◯

⨁⨁

Bleeding Complications

4 Observational Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW

◯◯

⨁⨁

1. Small sample size.

(3)

Supplemental Digital Content 7

eTable 7. Quality assessment for BMI-stratified dosing regimens using GRADE methodology

Number of

Studies Study design Limitations Inconsistency Indirectness Imprecision Other

considerations Quality of Evidence VTE Incidence

4 Observational;

Nonrandomized trial Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW

◯◯

⨁⨁

anti-Xa Concentration

3 Observational;

Nonrandomized trial Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW

◯◯

⨁⨁

Bleeding Complications 4

Observational;

Nonrandomized trial Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW

◯◯

⨁⨁

1. Small sample size; Mushtaq (2015) had only 4 patients in their pilot pediatric study.

Supplemental Digital Content 8

(4)

eTable 8. Quality assessment for continuous infusion dosing regimens using GRADE methodology

Number of

Studies Study design Limitations Inconsistency Indirectness Imprecision Other

considerations Quality of Evidence VTE Incidence

2 Observational Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None VERY LOW

◯◯◯

anti-Xa Concentration

2 Observational Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None VERY LOW

◯◯◯

Bleeding Complications

2 Observational Serious1 No serious

inconsistency

No serious indirectness

No serious

imprecision None VERY LOW

◯◯◯

1. Both studies lacked comparator groups. Shepherd et al. (2004) had a sample size of only 19 patients.

Supplemental Digital Content 9

(5)

eTable 9. Quality assessment for fixed-dose regimens using GRADE methodology

Number of Studies Study design Limitations Inconsistency Indirectness Imprecision Other

considerations Quality of Evidence VTE Incidence

26 Observational,

RCTs Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW

◯◯

⨁⨁

anti-Xa Concentration

10 Observational,

RCTs Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW

◯◯

⨁⨁

Bleeding Complications

23 Observational,

RCTs Serious1 No serious

inconsistency No serious

indirectness No serious

imprecision None LOW

◯◯

⨁⨁

1. Small sample size; loss to follow up.

Referensi

Dokumen terkait